Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Barkholt L et al. – The findings suggest that the use of ex vivo–expanded NK and NK–like T cells is safe and appears an attractive approach for further clinical evaluation in cancer patients.

Related Articles

Obesity linked to specific cancers
Internet Source, 11/05/09    Relevance Score: 97%

Screening for Cancer
MedLinePlus, 11/02/09    Relevance Score: 97%

Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09    Relevance Score: 97%

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09    Relevance Score: 97%

Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09    Relevance Score: 97%

Today in Clinical Pharmacology...keeping you current

Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment
Journal of Allergy and Clinical Immunology, 11/25/09

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09

High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations
Journal of Allergy and Clinical Immunology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address